Richard Cathomas

The SAKK cancer-specific geriatric assessment (C-SGA): a pilot study of a brief tool for clinical decision-making in older cancer patients

Gillian Roberts, Kerri Clough-Gorr, Lea Noti, 2013, BMC Medical Informatics and Decision Making.

Addition of Docetaxel to First-line Long-term Hormone Therapy in Prostate Cancer (STAMPEDE): Modelling to Estimate Long-term Survival, Quality-adjusted Survival, and Cost-effectiveness

Matthew R. Sydes, Duncan B. McLaren, Eleftherios Sideris, 2018, European urology oncology.

Lenvatinib in Advanced Radioiodine-Refractory Thyroid Cancer - A Retrospective Analysis of the Swiss Lenvatinib Named Patient Program

Frank Stenner, Sacha I. Rothschild, Stefan Zimmermann, 2018, Journal of Cancer.

Efficacy of Cetuximab in Metastatic Castration-Resistant Prostate Cancer Might Depend on EGFR and PTEN Expression: Results from a Phase II Trial (SAKK 08/07)

Rolf Jaggi, Christian Rothermundt, Ralph Schiess, 2012, Clinical Cancer Research.

Phase 2 trial of single-agent everolimus in chemotherapy-naive patients with castration-resistant prostate cancer (SAKK 08/08).

Ruedi Aebersold, Christian Rothermundt, Peter J Wild, 2013, European urology.